Related Experiment Videos
KIT ligand (mast cell growth factor) inhibits the growth of KIT-expressing melanoma cells
Abstract:
Previous studies in vivo and in vitro show that KIT kinase promotes normal melanocyte development and growth. However, the role of the KIT proto-oncogene in neoplastic melanocytes is not certain. We therefore examined KIT expression and function in human melanomas. Our results show that KIT mRNA was expressed in 12 of 28 melanoma cell lines (approximately 40%), mainly in those originating from pigmented tumors. Surprisingly, activation of KIT with mast cell growth factor (MGF) in melanoma cells produced biological responses opposite to those elicited in normal melanocytes. MGF inhibited rather than stimulated the growth of metastatic melanoma cell lines. The opposite effects may be due to aberrant signal transduction by KIT in melanoma cells in response to MGF. The in vitro inhibition of melanoma cells by MGF suggests that growth in vivo of this tumor is not promoted by KIT kinase activation, but rather that transformed melanocytes might regress when MGF is expressed in their immediate environment.
Insights
The KIT proto-oncogene, crucial for normal melanocyte growth, surprisingly inhibits melanoma cell proliferation when activated by mast cell growth factor (MGF). This suggests KIT
Area of Science:
- Oncology
- Molecular Biology
- Dermatology
Background:
- The KIT proto-oncogene is essential for normal melanocyte development and growth.
- Its precise role in neoplastic melanocytes, particularly in human melanomas, remains uncertain.
Purpose of the Study:
- To investigate KIT proto-oncogene expression and function in human melanoma cell lines.
- To determine the effect of KIT activation on melanoma cell growth and signaling.
Main Methods:
- Analysis of KIT messenger RNA (mRNA) expression in 28 human melanoma cell lines.
- In vitro stimulation of melanoma cells with mast cell growth factor (MGF) to assess biological responses.
Main Results:
- KIT mRNA was detected in approximately 40% of melanoma cell lines, predominantly in those from pigmented tumors.
- Contrary to its role in normal melanocytes, MGF inhibited the growth of metastatic melanoma cell lines.
- Aberrant KIT signal transduction in melanoma cells may explain the opposite biological responses to MGF.
Conclusions:
- KIT kinase activation does not promote melanoma tumor growth; instead, it may lead to regression.
- The findings suggest a potential therapeutic strategy targeting KIT signaling in melanoma.